Panagora Asset Management Inc Aeglea Bio Therapeutics, Inc. Transaction History

Panagora Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$3.51 - $8.48 $2,888 - $6,979	-823 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$6.42 - $9.0 $8,262 - $11,583	-1,287 Reduced 61.0%	823 $6,000
Q2 2019 Aug 09, 2019	BUY	$6.1 - $8.78 $12,871 - $18,525	2,110 New	2,110 $14,000
Q2 2018 Aug 14, 2018	SELL	$7.87 - $10.89 $125,699 - $173,935	-15,972 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$4.0 - $5.98 $15,124 - $22,610	3,781 Added 31.01%	15,972 $86,000
Q3 2017 Nov 14, 2017	BUY	$2.91 - $4.93 $35,475 - $60,101	12,191	12,191 $58,000

241K

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.